NeuroSense Therapeutics Ltd. (NRSN) Deferred Tax Liabilities, Gross

NeuroSense Therapeutics Ltd. Deferred Tax Liabilities, Gross

NeuroSense Therapeutics Ltd. (NRSN) had Deferred Tax Liabilities, Gross of $39.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.

Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net

us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-31

• 2025-12-31: Deferred Tax Liabilities, Gross $39.00K.
• 2024-12-31: Deferred Tax Liabilities, Gross $19.00K.
• 2023-12-31: Deferred Tax Liabilities, Gross $35.00K.